Evidence map›Paper›PMID 42439692›Full record

ReviewCells2026

Coregulatory Networks Remodel the Disease-Specific Functions of Orphan Nuclear Receptor TR4.

Yunlong Liu, Qing Yu, Shuyuan Cheng, Mengtian Ren, Xiuping Fu

Abstract readReview
In one paragraph

Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yunlong LiuSchool of Life Sciences, Tiangong University, Tianjin 300387, China.ORCID 0000-0002-0185-9293
Qing YuSchool of Life Sciences, Tiangong University, Tianjin 300387, China.ORCID 0009-0003-5509-7145
Shuyuan ChengSchool of Life Sciences, Tiangong University, Tianjin 300387, China.
Mengtian RenSchool of Life Sciences, Tiangong University, Tianjin 300387, China.ORCID 0009-0008-6966-5146
Xiuping FuSchool of Life Sciences, Tiangong University, Tianjin 300387, China.ORCID 0000-0002-8699-9518

Funding

Hebei Natural Science Foundation B2025110005National Natural Science Foundation of China 32401009, 22407100Shandong Provincial Postdoctoral Innovation Project SDCX-ZG-202502096
6 · The paper itself

Abstract

Testicular receptor 4 (TR4, NR2C2) is an orphan nuclear receptor involved in the regulation of metabolism, inflammation, cardiovascular disease, and cancer. Accumulating evidence indicates that TR4 exhibits functional plasticity, exerting protective or pathogenic effects depending on tissue and disease context, and sometimes displaying opposing roles within the same disease. However, the mechanisms underlying this functional duality remain poorly understood. Recent studies indicate that TR4 activity is determined not only by the receptor itself but also by dynamic coregulatory networks. Through interactions with coactivators, corepressors, epigenetic regulators, and environmental signaling pathways, TR4 integrates metabolic cues to generate context-dependent transcriptional programs. Coactivator networks centered on PGC-1α, steroid receptor coactivator (SRC) family members, and CBP/p300 support oxidative metabolism and anti-inflammatory responses, whereas RIP140-, NCoR/SMRT-, and HDAC-associated networks promote lipid accumulation, chronic inflammation, fibrosis, and tumor progression. Regulators such as JAZF1 further influence TR4 activity by reshaping coregulator recruitment and target-gene selection. In this review, we summarize the structural basis of TR4 regulation and discuss how coregulatory network remodeling governs its functions in metabolic, cardiovascular, inflammatory, and malignant diseases. We propose that TR4 functions as a context-dependent transcriptional platform whose activities are defined by its coregulatory landscape, providing a framework for precision therapies.

Indexed as

Nuclear Receptor Subfamily 2, Group C, Member 2AnimalsHumansInflammationNeoplasmsReceptors, SteroidReceptors, Thyroid HormoneNR2C2 protein, humanNuclear Receptor Subfamily 2, Group C, Member 2Receptors, SteroidReceptors, Thyroid Hormonecoregulatory networksorphan nuclear receptorprecision medicineTR4transcriptional plasticity

Identifiers

PMID42439692
PMCPMC13359851

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.